Brad Close explains why you shouldn't sit on your patent rights.
Patents are a one-size-fits-all legal right for inventions across every technology field. The varied fields create different legal necessities, so that diverse industries are often at odds over what they attempt to accomplish with patent rights.
This is demonstrated by comparing the industries of bio/pharma with mobile telecoms. With bio/pharma you have the requirement of massive, long-term, front-end investment to develop a few long-lived products that require minimal numbers of patents to protect, whereas mobile telecoms are characterised by an ever-changing environment in which a single product, like a smartphone, can incorporate inventions that are covered by hundreds, if not thousands, of patents.
It is therefore no surprise that strategic licensing plays out differently across different technical fields. With bio/pharma companies, patents tend to be used to exclude all competition on a blockbuster drug. In the mobile telecoms space, however, the “right to exclude” approach is rarely feasible.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at firstname.lastname@example.org
Patent, Patent litigation, bio, pharma, Motorola,